Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-045588
Filing Date
2025-05-20
Accepted
2025-05-19 21:17:53
Documents
48
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241519-10q_apimeds.htm   iXBRL 10-Q 354005
2 CERTIFICATION ea024151901ex31-1_apimeds.htm EX-31.1 10274
3 CERTIFICATION ea024151901ex31-2_apimeds.htm EX-31.2 10279
4 CERTIFICATION ea024151901ex32-1_apimeds.htm EX-32.1 3789
5 CERTIFICATION ea024151901ex32-2_apimeds.htm EX-32.2 3801
  Complete submission text file 0001213900-25-045588.txt   2736734

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE apus-20250331.xsd EX-101.SCH 23827
7 XBRL CALCULATION FILE apus-20250331_cal.xml EX-101.CAL 17981
8 XBRL DEFINITION FILE apus-20250331_def.xml EX-101.DEF 126943
9 XBRL LABEL FILE apus-20250331_lab.xml EX-101.LAB 227787
10 XBRL PRESENTATION FILE apus-20250331_pre.xml EX-101.PRE 137866
51 EXTRACTED XBRL INSTANCE DOCUMENT ea0241519-10q_apimeds_htm.xml XML 210805
Mailing Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08525
Business Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08525 609-751-4485
Apimeds Pharmaceuticals US, Inc. (Filer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42545 | Film No.: 25965980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)